Targeting the mutant Huntington's disease gene for silencing, while leaving the healthy gene untouched
Prana Biotech's PBT2 trial in Huntington's disease: what we know so far & what copper has to do with the mutant prote
A drug that activates an ancient cellular defense mechanism slows down HD in mice – but why didn’t the benefit last?
Canadian team decodes the tags that re-route the huntingtin protein within cells, helping explain how it becomes toxi
Positive results from tests of a new 'KMO inhibiting' drug in Huntington's disease mice
Is gene silencing as exciting as it sounds for HD, and what might the future hold?
HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc
Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies
Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD